Who owns the R2 REVLIMID/RITUXIMAB trademark?

The R2 REVLIMID/RITUXIMAB trademark is owned by Celgene Corporation.

What is the serial number for R2 REVLIMID/RITUXIMAB?

The USPTO serial number for R2 REVLIMID/RITUXIMAB is 88655362.

What is the registration number for R2 REVLIMID/RITUXIMAB?

R2 REVLIMID/RITUXIMAB is registered under USPTO registration number 6073615.

R2R

USPTO Trademark Record

REGISTERED

R2 REVLIMID/RITUXIMAB

Q: What class is the R2 REVLIMID/RITUXIMAB trademark registered in?

The R2 REVLIMID/RITUXIMAB trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

SN 88655362·Reg 6073615·Filed Oct 15, 2019

Owner Celgene Corporation

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

R2 REVLIMID/RITUXIMAB (Serial No. 88655362), Registration No. 6073615, is a registered US trademark filed on Oct 15, 2019 by Celgene Corporation. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

Section 8/9 declaration window: June 10, 2030

Mark Intelligence

R2 REVLIMID/RITUXIMAB (Reg. #6073615) is a registered US trademark that has been protecting its owner, Celgene Corporation, since 2019. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 15, 2019

SERIAL

88655362

REG#

6073615

REGISTERED

Jun 09, 2020

Owner

Applicant

Celgene Corporation

Entity

Corporation

State

Address

86 Morris Avenue, Summit, NJ, 07901

Country

Attorney

NameMarilyn F. Kelly

Law firm

Marilyn F. Kelly Bristol-Myers Squibb Company

Docket

CELG2019US

Address

PO BOX 4000, Trademark Dept., Mailstop D.4243, PRINCETON, NJ 08648, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateOct 15, 2019

Serial Number88655362

Registration No.6073615

Registration DateJun 09, 2020

Status DateJul 14, 2026

Published for OppositionMar 24, 2020

Next RenewalJune 10, 2030

Mark TypeDesign with words

Attorney DocketCELG2019US

Status DescriptionLive and registered, Section 8 and 15 accepted

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: May 28, 2019

First use in commerce: May 28, 2019

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: May 28, 2019

First use in commerce: May 28, 2019

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

34 events

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Jul 14, 2026

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Jul 14, 2026

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jul 13, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 15 RECEIVED

Apr 13, 2026

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jun 09, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Dec 09, 2022

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Dec 09, 2022

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Dec 09, 2022

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Dec 09, 2022

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Dec 09, 2022

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Dec 09, 2022

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

REGISTERED-PRINCIPAL REGISTER

Jun 09, 2020

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Mar 24, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 24, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 04, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Feb 17, 2020

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Feb 17, 2020

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 17, 2020

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Feb 17, 2020

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 17, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Feb 13, 2020

PREVIOUS ALLOWANCE COUNT WITHDRAWN

WITHDRAWN FROM PUB - OG REVIEW QUERY

Jan 28, 2020

WITHDRAWN FROM PUB - OG REVIEW QUERY

ASSIGNED TO LIE

Jan 13, 2020

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 08, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 07, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 07, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 07, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Jan 06, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jan 06, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 06, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 30, 2019

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Oct 22, 2019

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 19, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 18, 2019

NEW APPLICATION ENTERED

R2 REVLIMID/RITUXIMAB

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Celgene Corporation

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Marilyn F. Kelly

Resources

Company